Is an aromatase inhibitor more effective than tamoxifen in neoadjuvant endocrine therapy for breast cancer?
Roukos
Dimitrios H
DH
Surgical Oncology Research Unit, Ioannina University School of Medicine, Ioannina, Greece. droukos@cc.uoi.gr
Fatouros
Michael
M
Paraskevaidis
Evangelos
E
Kappas
Angelos M
AM